Skip to main content
Conferences and Meetings 802. Chemical Biology and Experimental Therapeutics: Poster II

802. Chemical Biology and Experimental Therapeutics: Poster II

Short name: updated-802. Chemical Biology and Experimental Therapeutics: Poster II-2025 Annual Meeting Poster Bundle Omics & Emerging Technologies
Course start date: 02/18/2026

Sections

General
0 activities

Gold salt phospholipid inhibits glutathione peroxidase 4 GPx4 and causes cell death in Mantle Cell Lymphoma Demonstration of single agent activity and synergy with ibrutinib
Momelotinib inhibition of JAK STAT in a mouse JAKV617F myelofibrosis model showed concurrent activation of p ERK and p AKT which was reversed by combination therapy using LP 182 a novel MEK PI3K mTOR inhibitor
The transition from myelodysplastic neoplasm to secondary acute myeloid leukemia is revealed by molecular analysis while functional drug screening demonstrates novel sensitivity patterns with clinical implication
The asns inhibitor asx 173 potentiates l asparaginase anticancer activity
Identification of novel potent and selective JAK2V617F inhibitors
Disrupting the PA2G4 NPM1 axis induces nucleolar stress in NPM1c AML
Silver nanoparticles trigger proteotoxicity in multiple myeloma cells via a mechanism distinct from bortezomib and remain efective in BTZ resistant myeloma
Vaccination targeting azacytidine induced neoantigens in the C1498 murine AML model

Vimeo Vimeo
8